Seres Therapeutics
MCRB
MCRB
148 hedge funds and large institutions have $642M invested in Seres Therapeutics in 2021 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 47 increasing their positions, 40 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.14% less ownership
Funds ownership: 4.34% → 4.2% (-0.14%)
9% less call options, than puts
Call options by funds: $3.72M | Put options by funds: $4.09M
Holders
148
Holding in Top 10
1
Calls
$3.72M
Puts
$4.09M
Top Buyers
| 1 | +$10.7M | |
| 2 | +$8.13M | |
| 3 | +$6.22M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$5.97M |
Top Sellers
| 1 | -$43.5M | |
| 2 | -$7.77M | |
| 3 | -$6.66M | |
| 4 |
JP Morgan Chase
New York
|
-$4.77M |
| 5 |
SG Americas Securities
New York
|
-$4.31M |